AMENDED AND RESTATED DEVELOPMENT AND COMMERCIAL SUPPLY AGREEMENTDevelopment and Commercial Supply Agreement • August 14th, 1998 • Miravant Medical Technologies • Pharmaceutical preparations • North Carolina
DEVELOPMENT AND COMMERCIAL SUPPLY AGREEMENTDevelopment and Commercial Supply Agreement • November 9th, 2021 • Ocugen, Inc. • Biological products, (no disgnostic substances)
This DEVELOPMENT AND COMMERCIAL SUPPLY AGREEMENT (this “Agreement”) is made and entered into as of the 29th day of September, 2021 (the “Effective Date”) by and between Bharat Biotech International Limited, whose registered office address is at Genome Valley, Shameerpet, Hyderabad – 500 078 Telangana India (together with its Affiliates, subsidiaries, successors and permitted assigns, “BBIL”), and Ocugen, Inc., with an address at 263 Great Valley Parkway, Malvern, PA 19355, USA (together with its Affiliates, subsidiaries, successors and permitted assigns, “Ocugen”).
